Fatima Adis Adamude

Dr. Fatima Adis Adamude


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2023 in Heliyon
Verified
Journal Article
Open access
AUABRAHAM UBHENIN
ABRAHAM UBHENIN
AAAdedotun A. Adefolalu
Adedotun A. Adefolalu
KOKelly Oriakhi
Kelly Oriakhi
FAFatima Adis Adamude
Fatima Adis Adamude
EDEmeka Dingwoke
Emeka Dingwoke
KOKingsley Omage
Kingsley Omage
This study is aimed at evaluating the anticancer effect of the aqueous extract of Caesalpinia pulcherrima (L.) Sw in 7,12-Dimethlbenz[a]anthracene (DMBA) – induced mammary cancer. Tumors were induced via a single intraperitoneal injection of DMBA (dissolved in olive oil) at a dose of 80 mg/kg body weight to the test rats and allowed to develop for about four months. They were treated with cyclophosphamide and an aqueous extract of Caesalpinia pulcherrima at doses of 10 and 250 mg/kg body weight, respectively, for 28 days. Serum levels of cancer antigen 125 (CA125), carcinoembryonic antigen (CEA) activity, cyclooxygenase-2 (COX-2), and cytochrome p450 oxidase (cytp450) activity, as well as other diagnostic enzymes, were estimated. The result revealed that DMBA is associated with a significant (p < 0.05) increase in the serum levels of CA125, CEA, COX-2, cytp450, lactate dehydrogenase (LDH), alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) of the rats, thus suggesting tumor-promoting and hepatotoxic effects of DMBA. There was also a significant (p < 0.05) reduction of serum levels of these cancer and liver biomarker enzymes in the groups treated with cyclophosphamide and Caesalpinia pulcherrima compared to the untreated group, thus suggesting anticancer activity of Caesalpinia pulcherrima. The anticancer effect of Caesalpinia pulcherrima was further confirmed by the disappearance of infiltrative fibrous cells and the absence of inflammatory cells from the photomicrographs of the rats treated with Caesalpinia pulcherrima. Our findings show that Caesalpinia pulcherrima possesses anticancer activity, and could protect against mammary cancer.

18 September 2026 in Frontiers in Ecology and Evolution
Verified
Journal Article
Open access
PDF file
EDEmeka Dingwoke
Emeka Dingwoke
FAFatima Adis Adamude
Fatima Adis Adamude
CNChukwuemeka Paul Nweje-Anyalowu
Chukwuemeka Paul Nweje-Anyalowu
CIChijioke Cyril Ilechukwu
Chijioke Cyril Ilechukwu
KMKingsley Onyekachi Moh
Kingsley Onyekachi Moh
DODesmond Obinna Obe
Desmond Obinna Obe
Snake venoms are complex and adaptive traits that show substantial variation within species. Although intraspecies venom diversity has been documented in the literature, the evolutionary mechanisms driving population-level venom variation and the strength of evidence supporting these mechanisms have not been systematically evaluated. This review aimed to synthesize population-level studies of snake venom evolution and assess the empirical support for the mechanisms underlying intraspecies venom diversification. A systematic review was carried out and reported in accordance with PRISMA 2020 guidelines. PubMed, Web of Science, and Scopus databases were searched for population-level studies examining snake venom variation using genomic, population genetics, transcriptomic, proteomic, or functional data. Eligible studies were required to provide explicit evolutionary interpretation. Information was extracted using a predefined framework that included the species, population scope, data type, analytical approach, evolutionary mechanisms, and key findings. Studies were categorized by strength of evolutionary inference based on their data and analytical approaches, ranging from descriptive and correlational evidence to population genetic testing and functional validation. The findings were synthesized narratively due to the heterogeneity in snake lineages and study design. The reviewed literature indicates that intraspecies venom diversity arises through multiple evolutionary pathways. At the population level, the most consistently supported mechanisms are natural selection acting on toxin gene coding sequences and regulatory divergence in toxin gene expression. Structural genomic processes, including gene duplication and copy number variation, are widespread but are not frequently linked directly to functional outcomes. Functional assays validating the biological effects of venom variation provide the strongest evidence for measurable biological consequences, while integration with evolutionary and ecological evidence can strengthen adaptive interpretations. Evidence at the population level indicates that snake venom diversity within species is shaped by a combination of genetic, regulatory, and functional processes, with no single mechanism operating universally. To synthesize heterogeneous population-level evidence on intraspecies venom diversification and guide future research, we propose an integrative conceptual framework to structure evidence. Integrative population-level studies that combine population genetic or genomic analyses with functional validation are essential for advancing understanding of venom evolutionary biology.